Unknown

Dataset Information

0

Identification and Preclinical Evaluation of the Bicyclic Pyrimidine ?-Secretase Modulator BMS-932481.


ABSTRACT: A triazine hit identified from a screen of the BMS compound collection was optimized for potency, in vivo activity, and off-target profile to produce the bicyclic pyrimidine ?-secretase modulator BMS-932481. The compound showed robust reductions of A?1-42 and A?1-40 in the plasma, brain, and cerebrospinal fluid of mice and rats. Consistent with the ?-secretase modulator mechanism, increases in A?1-37 and A?1-38 were observed, with no change in the total amount of A?1-x produced. No Notch-based toxicity was observed, and the overall preclinical profile of BMS-932481 supported its further evaluation in human clinical trials.

SUBMITTER: Boy KM 

PROVIDER: S-EPMC6421538 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications


A triazine hit identified from a screen of the BMS compound collection was optimized for potency, in vivo activity, and off-target profile to produce the bicyclic pyrimidine γ-secretase modulator BMS-932481. The compound showed robust reductions of Aβ<sub>1-42</sub> and Aβ<sub>1-40</sub> in the plasma, brain, and cerebrospinal fluid of mice and rats. Consistent with the γ-secretase modulator mechanism, increases in Aβ<sub>1-37</sub> and Aβ<sub>1-38</sub> were observed, with no change in the tota  ...[more]

Similar Datasets

| S-EPMC7931646 | biostudies-literature
| S-EPMC4789665 | biostudies-literature
| S-EPMC4007960 | biostudies-literature
| S-EPMC4115564 | biostudies-literature
| S-EPMC4789672 | biostudies-literature
| S-EPMC5716926 | biostudies-literature
| S-EPMC5516958 | biostudies-literature
| S-EPMC4931879 | biostudies-other
| S-EPMC8746326 | biostudies-literature
| S-EPMC4931877 | biostudies-other